Join us at the upcoming World Drug Repositioning Congress,

4 – 5 December 2012, 20 F Street NW Conference Center, Washington, DC, US

Biovista’s Aris Persidis is presenting a talk titled

Very large scale systematic drug repositioning as a business and technology driver

Topics covered include:

  • Big data technologies enabling the deployment of systemic drug repositioning as a core contributor to efficient drug development
  • Matching drug versus any disease or adverse events confers significant competitive advantages, including IP, payer differentiation, and innovation in target biology
  • Application to neurology and rare diseases